Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7220 p560
19 October 2002

This article
Reprint
Photocopy


News summary

 


Effect of herb medicine regulation on industry likely to be minimal

Only a small number of herbal products could be banned under a proposed European directive aimed at regulating the herbal industry, according to the Government.

The proposed directive on traditional herbal medicinal products, which could come into force by the end of 2004, will require manufacturers to provide evidence of at least 30 years of traditional use of a product. Following a broad assessment of 270 herbal ingredients, the Medicines Control Agency has initially concluded that only two or three cases would have a problem in demonstrating traditional use. In addition, consultations with herbalists on some 200 or so herbal combination products have indicated that these are also likely to fall under the definition of traditional use.

Although regulatory decisions will only be made on actual applications, the MCA says the potential for registering single ingredient and combination products under the directive will be wide, although a limited number of products might need to make some adjustment in their combination.

Commenting on the proposed directive last week, Health Minister Lord Hunt said it would protect public health and boost public confidence in herbal medicines: “Across the herbal sector there is broad support for a scheme that will systematically prevent poor quality and unsafe medicines reaching the UK market. It could cut through much of the hype and exaggeration about products which is still prevalent in some parts of the sector,” he said.

 

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal